Kynureninase deficiency ameliorated monocytic recruitment and severity in a mouse model of multiple sclerosis
Neurochemistry International · 2026-05 · 195 · 106141
DOI: 10.1016/j.neuint.2026.106141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurochemistry International, 2026-05. Verfasst von Koyo Yoshidomi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Medical Scien…. Hauptthemen laut MEDLINE: Monocytes, Multiple Sclerosis, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Multiple sclerosis (MS) is a common autoimmune demyelinating disease of the central nervous system (CNS). Although activation of the kynurenine (KYN) pathway has been observed in patients with MS, its pathological significance remains unclear. In this study, we investigated the role of the KYN pathway in MS using an experimental autoimmune encephalomyelitis (EAE) mouse model, a widely recognized animal model of MS. We found an increase in the expression of kynureninase (KYNU), a key enzyme in the KYN pathway that is specifically localized within monocytes in the spinal cord of EAE mice. This was accompanied by a significant accumulation of quinolinic acid (QUIN) in the spinal cord. Importantly, similar increases in KYNU expression and QUIN levels were observed in the spinal cord of proteolipid protein overexpressing mice (PLP-tg mice), another model of demyelination. Notably, KYNU knockout (KO) reduced EAE severity and monocyte recruitment to the spinal cord of EAE model mice. These findings suggest that the increase in KYNU expression and the subsequent accumulation of QUIN may contribute to the exacerbation of MS. Taken together, our results indicate that KYNU could be a novel therapeutic target for MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Medical Science, Toyoake, Aichi, Japan.
- Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Medical Science, Toyoake, Aichi, Japan; International Center for Brain Science (ICB…
- Department of Advanced Diagnostic System Development, Fujita Health University Graduate School of Medical Sciences, Toyoake, Aichi, Japan.
- Department of Cellular Function Analysis, Research Promotion and Support Headquarters, Fujita Health University, Toyoake, Aichi, Japan.
- Department of Disease Systems Analysis Medicine, Fujita Health University Graduate School of Medical Science, Toyoake, Aichi, Japan.
- Advanced Medical Research Center for Animal Models of Human Diseases, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yoshidomi, K., Kunisawa, K., Hasegawa, M., Kon, Y., Kosuge, A., Tanabe, M., Ojika, H., Yamamoto, Y., Fujigaki, H., Fujigaki, S., Tezuka, H., Saitoh, S., Kumamoto, K., Kugita, M., Nagao, S., Saito, K., Nabeshima, T., & Mouri, A. (2026). Kynureninase deficiency ameliorated monocytic recruitment and severity in a mouse model of multiple sclerosis. Neurochemistry International, 195, 106141. https://doi.org/10.1016/j.neuint.2026.106141
Vancouver
Yoshidomi K, Kunisawa K, Hasegawa M, Kon Y, Kosuge A, Tanabe M, et al. Kynureninase deficiency ameliorated monocytic recruitment and severity in a mouse model of multiple sclerosis. Neurochemistry International. 2026;195:106141. doi:10.1016/j.neuint.2026.106141
BibTeX
@article{Yoshidomi2026,
author = {Yoshidomi, Koyo and Kunisawa, Kazuo and Hasegawa, Masaya and Kon, Yuki and Kosuge, Aika and Tanabe, Moeka and Ojika, Haruto and Yamamoto, Yasuko and Fujigaki, Hidetsugu and Fujigaki, Suwako and Tezuka, Hiroyuki and Saitoh, Sei and Kumamoto, Kanako and Kugita, Masanori and Nagao, Shizuko and Saito, Kuniaki and Nabeshima, Toshitaka and Mouri, Akihiro},
title = {Kynureninase deficiency ameliorated monocytic recruitment and severity in a mouse model of multiple sclerosis},
journal = {Neurochemistry International},
year = {2026},
volume = {195},
pages = {106141},
doi = {10.1016/j.neuint.2026.106141}
}
EUVIMED